171 related articles for article (PubMed ID: 30400893)
21. Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys.
Puri SK; Dutta GP
Acta Trop; 2003 Apr; 86(1):35-40. PubMed ID: 12711101
[TBL] [Abstract][Full Text] [Related]
22. Tafenoquine and G6PD: a primer for clinicians.
Chu CS; Freedman DO
J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
Fukuda MM; Krudsood S; Mohamed K; Green JA; Warrasak S; Noedl H; Euswas A; Ittiverakul M; Buathong N; Sriwichai S; Miller RS; Ohrt C
PLoS One; 2017; 12(11):e0187376. PubMed ID: 29121061
[TBL] [Abstract][Full Text] [Related]
24. Killing of Plasmodium vivax by Primaquine and Tafenoquine.
Markus MB
Trends Parasitol; 2019 Nov; 35(11):857-859. PubMed ID: 31522991
[TBL] [Abstract][Full Text] [Related]
25. Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.
Warrasak S; Euswas A; Fukuda MM; Ittiverakul M; Miller RS; Krudsood S; Ohrt C
Int Ophthalmol; 2019 Aug; 39(8):1767-1782. PubMed ID: 30269312
[TBL] [Abstract][Full Text] [Related]
26. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
[TBL] [Abstract][Full Text] [Related]
27. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
[TBL] [Abstract][Full Text] [Related]
28. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
29. Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure.
Srinivasan S; Roy D; Chavas TEJ; Vlaskin V; Ho DK; Pottenger A; LeGuyader CLM; Maktabi M; Strauch P; Jackson C; Flaherty SM; Lin H; Zhang J; Pybus B; Li Q; Huber HE; Burke PA; Wesche D; Rochford R; Stayton PS
J Control Release; 2021 Mar; 331():213-227. PubMed ID: 33378692
[TBL] [Abstract][Full Text] [Related]
30. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
Dow GS; McCarthy WF; Reid M; Smith B; Tang D; Shanks GD
Malar J; 2014 Feb; 13():49. PubMed ID: 24502679
[TBL] [Abstract][Full Text] [Related]
31. Tafenoquine: a promising new antimalarial agent.
Crockett M; Kain KC
Expert Opin Investig Drugs; 2007 May; 16(5):705-15. PubMed ID: 17461742
[TBL] [Abstract][Full Text] [Related]
32. Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of
Watson JA; Commons RJ; Tarning J; Simpson JA; Llanos Cuentas A; Lacerda MVG; Green JA; Koh GCKW; Chu CS; Nosten FH; Price RN; Day NPJ; White NJ
Elife; 2024 Feb; 13():. PubMed ID: 38323801
[TBL] [Abstract][Full Text] [Related]
33. Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of
Kostić M; Milosavljević MN; Stefanović S; Ranković G; Janković SM
J Chemother; 2020 Feb; 32(1):21-29. PubMed ID: 31524099
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.
St Jean PL; Koh GCKW; Breton JJ; Espino FEJ; Hien TT; Krudsood S; Lacerda MVG; Llanos-Cuentas A; Lon C; Mohammed R; Namaik-Larp CS; Pereira DB; Saunders DL; Velez ID; Yilma D; Villegas MF; Duparc S; Green JA
Pharmacogenet Genomics; 2020 Sep; 30(7):161-165. PubMed ID: 32433338
[TBL] [Abstract][Full Text] [Related]
35. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
Commons RJ; McCarthy JS; Price RN
Med J Aust; 2020 Mar; 212(4):152-153.e1. PubMed ID: 32036613
[No Abstract] [Full Text] [Related]
36. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
Kitchener S; Nasveld P; Edstein MD
Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
[TBL] [Abstract][Full Text] [Related]
37. Korean vivax malaria. II. Curative treatment with pamaquine and primaquine.
ALVING AS; HANKEY DD; COATNEY GR; JONES R; COKER WG; GARRISON PL; DONOVAN WN
Am J Trop Med Hyg; 1953 Nov; 2(6):970-6. PubMed ID: 13104805
[No Abstract] [Full Text] [Related]
38. Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys.
Schmidt LH
Antimicrob Agents Chemother; 1983 Nov; 24(5):615-52. PubMed ID: 6660845
[TBL] [Abstract][Full Text] [Related]
39. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (
Rueangweerayut R; Bancone G; Harrell EJ; Beelen AP; Kongpatanakul S; Möhrle JJ; Rousell V; Mohamed K; Qureshi A; Narayan S; Yubon N; Miller A; Nosten FH; Luzzatto L; Duparc S; Kleim JP; Green JA
Am J Trop Med Hyg; 2017 Sep; 97(3):702-711. PubMed ID: 28749773
[TBL] [Abstract][Full Text] [Related]
40. Historical 8-Aminoquinoline Combinations: Not All Antimalarial Drugs Work Well Together.
Shanks GD
Am J Trop Med Hyg; 2022 Nov; 107(5):964-967. PubMed ID: 36252799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
